The results of this study suggest that with increasing stages of cutaneous melanoma, there is a decrease in the number of mast cells both in the intratumoral and peritumoral zones, with the most pronounced reduction observed in Chymase-positive cells at later stages of the disease. This evidence concerns the gene CMA1 and cutaneous melanoma.